Cytokine Signalling Forum
Congress Author Podcast - ACR 2019 Upadacitinib
- Autore: Vários
- Narratore: Vários
- Editore: Podcast
- Durata: 0:26:27
- Altre informazioni
Informações:
Trama
In this edition experts, including Professor Smolen and Professor McInnes, present the latest data for the recently approved JAK inhibitor, upadacitinib. The presentations include: data from the SELECT trials, safety analyses, switching from TNF inhibitors, and the mode of action of upadacitinib.
